Frank Romanski of Lonza Capsugel dives into the excipient side of manufacturing and the emerging prevalence of digitalization ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

CPHI Frankfurt 2025 highlighted a pharmaceutical industry in flux, navigating the rapid acceleration of artificial intelligence (AI) integration, profound shifts in global supply chain management, and ...

Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...

End-to-end CDMO services simplify drug development for small biopharma companies, reducing complexity, time, and costs while ...

Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

As a part of its CPHI Frankfurt 2025 coverage, Pharmaceutical Technology ® interviewed Sriman Banerjee, PhD, executive ...

In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

The Critical Medicines Act (CMA) addresses supply chain vulnerabilities by redefining procurement criteria, emphasizing quality, security, and environmental standards. European manufacturers gain ...

Maggie Saykali, Cefic, explains that Western pharma vulnerability stems from market loss to Asia, caused largely by ...